Immunotope, Inc.
Records under this name other than the patents Immunotope, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 4 of 4 · Back to Immunotope, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,907,842 | Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer Lapsed on the fee record Ended Mar 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended Mar 6, 2026 | From the USPTO record |
| US 9,624,284 | Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer Lapsed on the fee record Ended Apr 18, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2025 | From the USPTO record |
| US 7,919,467 | Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment, and Diagnosis of Cancer Lapsed on the fee record Ended Apr 5, 2019 · High confidence | Lapsed on the fee record | Ended Apr 5, 2019 | High confidence |
| US 7,083,789 | Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment, and Diagnosis of Cancer Formerly held Lapsed on the fee record Ended Aug 1, 2018 · High confidence | Lapsed on the fee record | Ended Aug 1, 2018 | High confidence |